INTRODUCTION
The presence of multiple neoplasms in one patient is an uncommon event. Its occurrence ranges from 1.2% to 4.5% of cancer patients in autopsy and clinical studies. 1 Different neoplasms may be synchronous, when separated by an interval shorter than six months, or metachronous, when separated by a greater interval. 1 It is generally easier to detect metachronous multiple neoplasia than to detect the synchronous type, since metachronous neoplasia produces signs and symptoms that are distinct in time and anatomical site in patients who are under close supervision to guard against recurrence of their initial neoplasm. Occasionally, however, the presence of another malignancy is an unexpected fi nding during the follow-up for a previously diagnosed neoplasm. Such diagnoses represent challenges for the practitioner, and the presence of an unexpected second malignancy may pose dilemmas with regard to diagnosis and treatment. 1 
OBJECTIVE
The rarity of occurrences of multiple neoplasms and the need to alert both pathologists and clinicians regarding this possibility in daily practice prompted us to report on seven such cases diagnosed in our service.
METHODS
This was a descriptive retrospective study on cancer patients diagnosed at the university hospital of Universidade Estadual de Campinas (Unicamp) and at Hospital do Câncer A. C. Camargo, São Paulo, Brazil. The patient sample consisted of seven cases of concomitant detection of hematological neoplasm and carcinoma.
Biopsy and surgical specimens from these patients were fixed in 10% formalin and embedded in paraffi n. Immunohistochemical analysis was performed using antibodies for epithelial and lymphoid markers, all provided by Dakocytomation, Carpenteria, California, United States. Heat-induced antigen retrieval was achieved using a steamer. The samples were developed using the EnVision peroxidase technique (Dakopatts, code K1491).
RESULTS
Data on all the patients were obtained from their clinical fi les and are summarized in Table 1 . Four patients were female and three, male. Their ages ranged from 16 to 79 years (mean of 61.4 years). In cases 1, 2 and 3, the diagnosis of the two neoplasms was made simultaneously, while in cases 4 and 6, carcinoma was diagnosed fi rst, and in cases 5 and 7, the hematological neoplasm was diagnosed fi rst. All of the diagnoses were confi rmed by histopathological and immunohistochemical analysis. One example of simultaneous infiltration of lymph nodes by Hodgkin's lymphoma and metastatic carcinoma cells (case 1) is shown in Figure 1 .
DISCUSSION
In the present report, seven cases of adenocarcinoma associated with lymphoma in lymph nodes are described, with analysis from surgical specimens. Second primary malignancies in patients with a history of malignant tumors have been reported with increasing frequency over recent years.
2 Some combinations of tumors appear to have no readily detectable apparent common link or pathogenesis. Other combinations, in which lymphomas represent one of the components, have led to speculation concerning common underlying pathogenetic mechanisms that might contribute towards the development and growth of tumors. 1 Various factors that might contribute towards the occurrence of multiple neo-plasms have been suggested. Some authors have considered that the most important ones are genetic susceptibility (for example, mutations in the P53 gene and defects in other genes responsible for DNA repair), advanced age and depressed cell immunity (immunosuppression produced by the first tumor or individual susceptibility). 2 Other factors suggested in the literature have been growth factor production from the original tumor and exposure to common inducing agents, such as smoking or predisposition to carcinomas of the head and neck, lung, liver and bladder. Production of interleukin 6 in cases of renal carcinoma, for instance, has been reported to be a factor in the pathogenesis of multiple myeloma. Another association of tumors for which common pathogenesis is ascribed consists of gastric mucosa-associated lymphoid tissue (MALT-lymphoma) and gastric adenocarcinoma. Helicobacter pylori seems to be implicated in both of these entities. 4 The frequency of H. pylori has been reported to be 45%-90% in patients with gastric adenocarcinoma, and 56%-100% in those with gastric MALTlymphoma. 4 On the other hand, H. pylori was found in 25%-38% of large B-cell gastric lymphomas. 4 Case 3 of our series is peculiar, both because this bacteria was detected and because associations of diffuse-type gastric carcinoma with large B-cell lymphoma is reported to be extremely rare. 4 Gastric adenocarcinoma concomitant with lymphocyte-predominant Hodgkin's lymphoma (our case 1) has not previously been described. An association between solid cancers and splenic marginal zone lymphoma (case 4) has already been reported.
The occurrence of collision tumors in lymph nodes infiltrated by lymphoma is exceptional. It is possibly due to obliteration of the lymphatic channels by the proliferating lymphoid cells, or to modification of adhesion molecules, thereby preventing circulation or implantation of metastatic cells. It has been also reported that neoplastic lymphoid cells could locally reduce tissue necrosis factor or interleukin-1-induced adhesion of neoplastic cells to the endothelial layer of lymph nodes. 3 Multiple malignant tumors may occur in the context of hereditary cancer syndromes. They are derived from germline mutations of three major genes that are closely related to cell cycles, tumor suppression and differentiation, thereby potentially leading to carcinogenesis. These are oncogenes, such as the RET (rearranged during transfection) gene, which is responsible for multiple endocrine neoplasia type 2, and tumor suppressor genes, such as P53, which accounts for the Li-Fraumeni syndrome. Stability genes may also be affected, such as those involved in Fanconi's anemia. 5 Patients with these syndromes frequently present concomitant neoplasms at specific sites, mostly at a younger age, with features differing from those of the seven cases reported in this study.
Although infrequent, the cases presented here should alert clinicians and pathologists to the possibility that concomitant neoplasms may exist, in order to prevent inaccurate or delayed diagnosis and staging. Lymph nodes should be carefully examined when searching for metastasis, because of the possibility of a second hematological malignancy. Lymph node biopsy in patients with a known primary malignancy does not always indicate metastasis.
2 Diagnosis of such associations is critical because the therapies and prognoses are usually different. This type of association poses histopathological diagnostic difficulty.
CONCLUSION
Whenever uncommon cell types or suspicious morphological features are seen in histopathological analysis of neoplasms or in suspect lymph nodes, the possibility of concomitant neoplasia should be considered. In difficult cases, immunohistochemical analysis is essential.
